---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000067"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T18:24:33.906365+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lifecore adds ~$8M non-dilutive liquidity via lender amendments; assigns Curation Foods assets

## Summary
- $5.5M prepayment from term lender as advance on future purchases; lender can apply to invoices in 2026.
- FILO amendment adds ~$2.5M incremental revolver capacity under ABL; margin SOFR+4.25%, annual interest +~$44k.
- Assignment for benefit of creditors of wholly owned subsidiary Curation Foods to SG Service Co. for liquidation.
- Pro forma cash post-initiatives would be $11.0M (up from $3.0M); total debt $178.9M.
- 2024 Annual Incentive Plan amended: CEO & CFO cash incentives to be paid in unrestricted common stock.

## SEC filing metadata
- accession: 0001005286-24-000067
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000067/0001005286-24-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000067/lndc-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000067
- JSON: https://secwatch.observer/filing/0001005286-24-000067.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000067.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.